Kura Oncology (KURA) Market Cap to FCF (2015 - 2026)
Kura Oncology (KURA) Market Cap to FCF (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Market Cap to FCF |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
-5.37 Mn |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
-3.22 Mn |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-37,563.72 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-169,108.42 |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
-8,971.08 |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
30.34 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
-636.65 |
| 10 |
Kura Oncology |
763.82 Mn |
763.82 Mn |
18.00 Mn |
-9.04 |
| Date | Value |
|---|
| Jun 8, 2026 |
-9.04 |
| Jun 5, 2026 |
-9.17 |
| Jun 4, 2026 |
-9.20 |
| Jun 3, 2026 |
-9.08 |
| Jun 2, 2026 |
-9.39 |
| Jun 1, 2026 |
-9.49 |
| May 29, 2026 |
-10.70 |
| May 28, 2026 |
-10.46 |
| May 27, 2026 |
-10.74 |
| May 26, 2026 |
-10.95 |
| May 22, 2026 |
-11.80 |
| May 21, 2026 |
-11.67 |
| May 20, 2026 |
-10.83 |
| May 19, 2026 |
-9.42 |
| May 18, 2026 |
-9.66 |
| May 15, 2026 |
-9.67 |
| May 14, 2026 |
-10.19 |
| May 13, 2026 |
-9.95 |
| May 12, 2026 |
-10.16 |
| May 11, 2026 |
-9.98 |
